For the first time, the Federal Trade Commission is being sued over the use of history.
The American Medical Association (AMA) is once again tampering with your health freedom.
Did you know that: A drug company petitioned the FDA to ban a B vitamin in order to protect its own drug product?
The latest attack on bio-identical hormones comes from FDA staffers telling Congress that even though estriol is the weakest estrogen, it is being prescribed to women in “mega dosages.” They are saying that this makes it potentially harmful, which is why they are insisting on doctors having to file an IND (investigational new drug) application.
AAHF is pleased to announce that the Food and Drug Administration must now classify mercury fillings! We congratulate Consumers for Dental Choices, Moms Against Mercury, International Academy of Oral and Metal Toxicology, and all other groups and individuals who have dedicated years to the issue of the dangers of dental mercury.
The FDA attack on bio-identical hormones therapy, seemingly in conjuncture with Wyeth Pharmaceutical, has mobilized the health freedom community.
The statistics below show the amount of money being spent on lobbying by conventional medicine. The 2.5 million health professions who are not allopathic doctors and who are authorized to deliver direct care to the public are not well served by this model. This is why AAHF is about the right of the consumer to […]
From our friends at Consumers for Dental Choice comes news that the Food & Drug Administration, Associate Commissioner Norris Alderson has declared that mercury amalgams are “…not for MY grandchildren.”
Our international affiliate, Alliance for Natural Health (ANH) has just released an announcement that the European Commission has moved the ‘goalposts’ on the procedure that aims to standardize allowed generic health claims on foods in the European Union by 2010. In addition, the ANH claims that the Commission has not met its obligations with regard […]
The Food and Drug Administration (FDA) recently released a Public Health Advisory on Edetate Disodium (EDTA). The advisory reflects FDA’s current analysis of data available concerning this drug. The advisory is meant to alert patients and healthcare professionals about EDTA.